Minerva Surgical, Inc.
UTRS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $50,294 | $52,103 | $37,768 | $26,012 |
| % Growth | -3.5% | 38% | 45.2% | – |
| Cost of Goods Sold | $23,052 | $21,580 | $18,648 | $14,207 |
| Gross Profit | $27,242 | $30,523 | $19,120 | $11,805 |
| % Margin | 54.2% | 58.6% | 50.6% | 45.4% |
| R&D Expenses | $5,443 | $5,292 | $3,324 | $935 |
| G&A Expenses | $14,370 | $22,183 | $8,212 | $8,382 |
| SG&A Expenses | $52,698 | $54,376 | $31,186 | $30,507 |
| Sales & Mktg Exp. | $38,328 | $32,193 | $22,974 | $22,125 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $58,141 | $59,668 | $34,510 | $31,442 |
| Operating Income | -$30,899 | -$29,145 | -$15,390 | -$19,637 |
| % Margin | -61.4% | -55.9% | -40.7% | -75.5% |
| Other Income/Exp. Net | -$3,202 | $7,690 | -$3,005 | -$32,409 |
| Pre-Tax Income | -$34,101 | -$21,455 | -$18,395 | -$52,046 |
| Tax Expense | $11 | $9 | -$132 | $0 |
| Net Income | -$34,112 | -$21,464 | -$18,263 | -$52,046 |
| % Margin | -67.8% | -41.2% | -48.4% | -200.1% |
| EPS | -23.68 | -14.98 | -17.91 | -75.29 |
| % Growth | -58.1% | 16.4% | 76.2% | – |
| EPS Diluted | -23.68 | -14.98 | -17.91 | -75.29 |
| Weighted Avg Shares Out | 1,440 | 1,433 | 1,020 | 927 |
| Weighted Avg Shares Out Dil | 1,440 | 1,433 | 1,020 | 927 |
| Supplemental Information | – | – | – | – |
| Interest Income | $89 | $10 | $81 | $135 |
| Interest Expense | $3,222 | $11,728 | $12,140 | $17,579 |
| Depreciation & Amortization | $10,806 | $10,620 | $7,076 | $1,981 |
| EBITDA | -$20,073 | $893 | $821 | -$17,656 |
| % Margin | -39.9% | 1.7% | 2.2% | -67.9% |